Lawrence D, Livingston A
Br J Pharmacol. 1981 Jun;73(2):435-42. doi: 10.1111/j.1476-5381.1981.tb10440.x.
1 The interaction of naloxone with various anaesthetics was studied both in vivo and in vitro.2 Naloxone (10 mg/kg) did not significantly alter the anaesthetic duration of halothane, diethylether, ketamine, pentobarbitone or Althesin.3 Naloxone (10 mg/kg) reduced the analgesic activity of nitrous oxide, ketamine and morphine in the rat tail-flick test. With the exception of pentobarbitone and Althesin, the other anaesthetic agents also induced analgesia but were not antagonized by naloxone.4 Specific [(3)H]-dihydromorphine binding was displaced by the opiates naloxone (IC(50) = 7.6 nm), methionine-enkephalin (Met-enkephalin, IC(50) = 40 nm) and morphine (IC(50) = 54 nm). Similarly, displacement was observed with xylazine (IC(50) = 9 mum), ketamine (IC(50) = 130 mum) and Althesin (IC(50) = 150 mum); other anaesthetics agents tested were inactive in mm concentrations.5 Ketamine (IC(50) = 200 mum) and xylazine (IC(50) = 9.5 mum) were also capable of displacing specific [(3)H]-D-Ala(2)-enkephalin (D-Leu) binding, as were morphine (IC(50) = 95 nm) and Met-enkephalin (IC(50) = 40 nm).6 On the stimulated guinea-pig ileum, Met-enkephalin and morphine inhibited the contractions, the IC(50) values were 30 nm and 50 nm respectively. The anaesthetics ketamine (IC(50) = 10 mum) and Althesin (IC(50) = 8 mum) were active. Xylazine (IC(50) = 12 nm) exhibited considerable potency in inhibiting the contractions on this preparation. Naloxone 0.5 mum produced a 1000 fold shift in the opiate dose-response curve but the anaesthetic responses showed only slight sensitivity to antagonism by naloxone.7 The activity of Althesin was found to be due to the vehicle in which this anaesthetic is solubilised.8 Whilst several anaesthetic agents showed analgesic activity, specific dihydromorphine binding displacement or guinea pig ileum inhibiting activity, these effects showed variable sensitivity to naloxone.
在体内和体外研究了纳洛酮与各种麻醉剂的相互作用。
纳洛酮(10毫克/千克)并未显著改变氟烷、乙醚、氯胺酮、戊巴比妥或阿耳法赛因的麻醉持续时间。
在大鼠甩尾试验中,纳洛酮(10毫克/千克)降低了氧化亚氮、氯胺酮和吗啡的镇痛活性。除戊巴比妥和阿耳法赛因外,其他麻醉剂也诱导了镇痛作用,但未被纳洛酮拮抗。
阿片类药物纳洛酮(半数抑制浓度[IC(50)] = 7.6纳米)、甲硫氨酸脑啡肽(脑啡肽,IC(50) = 40纳米)和吗啡(IC(50) = 54纳米)取代了特异性[(3)H]-二氢吗啡结合。同样,赛拉嗪(IC(50) = 9微米)、氯胺酮(IC(50) = 130微米)和阿耳法赛因(IC(50) = 150微米)也观察到了取代作用;所测试的其他麻醉剂在毫米浓度下无活性。
氯胺酮(IC(50) = 200微米)和赛拉嗪(IC(50) = 9.5微米)也能够取代特异性[(3)H]-D-丙氨酸(2)-脑啡肽(D-亮氨酸)结合,吗啡(IC(50) = 95纳米)和脑啡肽(IC(50) = 40纳米)也是如此。
在刺激的豚鼠回肠上,脑啡肽和吗啡抑制收缩,IC(50)值分别为30纳米和50纳米。麻醉剂氯胺酮(IC(50) = 10微米)和阿耳法赛因(IC(50) = 8微米)有活性。赛拉嗪(IC(50) = 12纳米)在抑制该制剂收缩方面表现出相当的效力。0.5微米的纳洛酮使阿片剂量反应曲线发生1000倍的偏移,但麻醉反应对纳洛酮拮抗仅表现出轻微敏感性。
发现阿耳法赛因的活性归因于溶解该麻醉剂的溶媒。
虽然几种麻醉剂表现出镇痛活性、特异性二氢吗啡结合取代或豚鼠回肠抑制活性,但这些作用对纳洛酮的敏感性各不相同。